Loss of the Cyclin-Dependent Kinase Inhibitor 1 in the Context of Brachyury-Mediated Phenotypic Plasticity Drives Tumor Resistance to Immune Attack
The acquisition of mesenchymal features by carcinoma cells is now recognized as a driver of metastasis and tumor resistance to a range of anticancer therapeutics, including chemotherapy, radiation, and certain small-molecule targeted therapies. With the recent successful implementation of immunother...
Main Authors: | Duane H. Hamilton, Kristen K. McCampbell, Claudia Palena |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fonc.2018.00143/full |
Similar Items
-
The T-box transcription factor Brachyury regulates epithelial–mesenchymal transition in association with cancer stem-like cells in adenoid cystic carcinoma cells
by: Shimoda Miyuki, et al.
Published: (2012-08-01) -
The Roles of Embryonic Transcription Factor BRACHYURY in Tumorigenesis and Progression
by: Ming Chen, et al.
Published: (2020-06-01) -
Transfection of T-Box Transcription Factor <i>BRACHYURY</i> and <i>SOX2</i> Synergistically Promote Self-Renewal and Invasive Phenotype in Oral Cancer Cells
by: Naonari Akimoto, et al.
Published: (2018-11-01) -
The Role of Transcriptional Factor Brachyury on Cell Cycle Regulation in Non-small Cell Lung Cancer
by: Jingyi Xu, et al.
Published: (2020-07-01) -
Clinicopathologic features of four rare types of chordomas, confirmed by brachyury immunostaining
by: Bharat Rekhi, et al.
Published: (2017-01-01)